Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian M Alexander

Showing results (71-80 of 159) with videos related to

Pageof 16
Sort By:
Lung Cancer (Amsterdam, Netherlands)|August 22, 2020
Retrospective analysis of real-world data to determine clinical outcomes of patients with advanced non-small cell lung cancer following cell-free circulating tumor DNA genomic profilingRussell Madison, Alexa B Schrock, Emily Castellanos, et al.
Neuro-Oncology|May 13, 2017
Quantitative imaging biomarkers for risk stratification of patients with recurrent glioblastoma treated with bevacizumabPatrick Grossmann, Vivek Narayan, Ken Chang, et al.
JCO Precision Oncology|September 3, 2021
Characterization of Non-Small-Cell Lung Cancers With MET Exon 14 Skipping Alterations Detected in Tissue or Liquid: Clinicogenomics and Real-World Treatment PatternsJessica K Lee, Russell Madison, Anthony Classon, et al.
International Journal of Radiation Oncology, Biology, Physics|June 19, 2012
Importance of extracranial disease status and tumor subtype for patients undergoing radiosurgery for breast cancer brain metastasesMichael A Dyer, Paul J Kelly, Yu-Hui Chen, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2020
Prediction of Outcomes with a Computational Biology Model in Newly Diagnosed Glioblastoma Patients Treated with Radiation Therapy and TemozolomideRifaquat Rahman, Lorenzo Trippa, Stephanie Alden, et al.
International Journal of Radiation Oncology, Biology, Physics|June 5, 2007
Dosimetric feasibility of hypofractionated proton radiotherapy for neoadjuvant pancreatic cancer treatmentKevin R Kozak, Lisa A Kachnic, Judith Adams, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 6, 2020
CYLD mutation characterizes a subset of HPV-positive head and neck squamous cell carcinomas with distinctive genomics and frequent cylindroma-like histologic featuresErik A Williams, Meagan Montesion, Brian M Alexander, et al.
Practical Radiation Oncology|November 26, 2015
Evaluation of initial setup accuracy and intrafraction motion for spine stereotactic body radiation therapy using stereotactic body framesZhaohui Han, John C Bondeson, John H Lewis, et al.
Cancer|December 7, 2011
A single-nucleotide polymorphism in the methylene tetrahydrofolate reductase (MTHFR) gene is associated with risk of radiation pneumonitis in lung cancer patients treated with thoracic radiation therapyRaymond H Mak, Brian M Alexander, Kofi Asomaning, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2014
Cancer-specific outcomes among young adults without health insuranceAyal A Aizer, Benjamin Falit, Mallika L Mendu, et al.
Pageof 16

Showing results (71-80 of 159) with videos related to

Sort By:
Pageof 16
Lung Cancer (Amsterdam, Netherlands)|August 22, 2020
Retrospective analysis of real-world data to determine clinical outcomes of patients with advanced non-small cell lung cancer following cell-free circulating tumor DNA genomic profilingRussell Madison, Alexa B Schrock, Emily Castellanos, et al.
Neuro-Oncology|May 13, 2017
Quantitative imaging biomarkers for risk stratification of patients with recurrent glioblastoma treated with bevacizumabPatrick Grossmann, Vivek Narayan, Ken Chang, et al.
JCO Precision Oncology|September 3, 2021
Characterization of Non-Small-Cell Lung Cancers With MET Exon 14 Skipping Alterations Detected in Tissue or Liquid: Clinicogenomics and Real-World Treatment PatternsJessica K Lee, Russell Madison, Anthony Classon, et al.
International Journal of Radiation Oncology, Biology, Physics|June 19, 2012
Importance of extracranial disease status and tumor subtype for patients undergoing radiosurgery for breast cancer brain metastasesMichael A Dyer, Paul J Kelly, Yu-Hui Chen, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2020
Prediction of Outcomes with a Computational Biology Model in Newly Diagnosed Glioblastoma Patients Treated with Radiation Therapy and TemozolomideRifaquat Rahman, Lorenzo Trippa, Stephanie Alden, et al.
International Journal of Radiation Oncology, Biology, Physics|June 5, 2007
Dosimetric feasibility of hypofractionated proton radiotherapy for neoadjuvant pancreatic cancer treatmentKevin R Kozak, Lisa A Kachnic, Judith Adams, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 6, 2020
CYLD mutation characterizes a subset of HPV-positive head and neck squamous cell carcinomas with distinctive genomics and frequent cylindroma-like histologic featuresErik A Williams, Meagan Montesion, Brian M Alexander, et al.
Practical Radiation Oncology|November 26, 2015
Evaluation of initial setup accuracy and intrafraction motion for spine stereotactic body radiation therapy using stereotactic body framesZhaohui Han, John C Bondeson, John H Lewis, et al.
Cancer|December 7, 2011
A single-nucleotide polymorphism in the methylene tetrahydrofolate reductase (MTHFR) gene is associated with risk of radiation pneumonitis in lung cancer patients treated with thoracic radiation therapyRaymond H Mak, Brian M Alexander, Kofi Asomaning, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2014
Cancer-specific outcomes among young adults without health insuranceAyal A Aizer, Benjamin Falit, Mallika L Mendu, et al.
Pageof 16